Ishiyama Akiharu, Hibi Kenji, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro, Ito Katsuki, Nakao Akimasa
Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Anticancer Res. 2006 Jan-Feb;26(1A):195-8.
The PTCH expression level in esophageal squamous cell carcinoma (SCC) was examined.
To test whether PTCH can serve as a candidate marker for esophageal SCC, a quantitative reverse transcription (RT) -PCR for the PTCH gene was performed and the possible relationship between PTCH gene expression levels and clinicopathological findings in esophageal SCC was evaluated.
A low PTCH expression score was observed in 18 out of 29 (62%) esophageal SCCs and it was significantly correlated with a poor prognosis in esophageal SCC patients (p = 0.0073).
These results suggest that PTCH might serve as a new parameter for the prediction of prognosis in esophageal SCC.
检测食管鳞状细胞癌(SCC)中PTCH的表达水平。
为检测PTCH是否可作为食管SCC的候选标志物,进行了PTCH基因的定量逆转录(RT)-PCR,并评估了PTCH基因表达水平与食管SCC临床病理结果之间的可能关系。
29例食管SCC中有18例(62%)观察到PTCH低表达评分,且其与食管SCC患者的不良预后显著相关(p = 0.0073)。
这些结果表明,PTCH可能作为预测食管SCC预后的新参数。